Huijian Wu

School Of Bioengineering & Key Laboratory Of Protein Modification And Disease
Dalian, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Pan-EGFR inhibitor targeting EGFR 19del, L858R/T790M and C797S triple-mutations: Design, synthesis, and pharmacological evaluation.

Pan-EGFR inhibitor targeting EGFR 19del, L858R/T790M and C797S triple-mutations: Design, synthesis, and pharmacological evaluation.

Journal: Bioorganic chemistry

Published: June 19, 2025

The Role and Mechanism of Deubiquitinase USP7 in Tumor-Associated Inflammation.

The Role and Mechanism of Deubiquitinase USP7 in Tumor-Associated Inflammation.

Journal: Biomedicines

Published: October 18, 2024

FMNL3 Promotes Migration and Invasion of Breast Cancer Cells via Inhibiting Rad23B-Induced Ubiquitination of Twist1.

FMNL3 Promotes Migration and Invasion of Breast Cancer Cells via Inhibiting Rad23B-Induced Ubiquitination of Twist1.

Journal: Journal of cellular physiology

Published: June 10, 2024

Association between breastfeeding, mammographic density, and breast cancer risk: a review.

Association between breastfeeding, mammographic density, and breast cancer risk: a review.

Journal: International breastfeeding journal

Published: May 15, 2024

Inhibition of ABI2 ubiquitination-dependent degradation suppresses TNBC cell growth via down-regulating PI3K/Akt signaling pathway.

Inhibition of ABI2 ubiquitination-dependent degradation suppresses TNBC cell growth via down-regulating PI3K/Akt signaling pathway.

Journal: Cancer cell international

Published: February 16, 2024

GATA4 regulates the transcription of MMP9 to suppress the invasion and migration of breast cancer cells via HDAC1-mediated p65 deacetylation.

GATA4 regulates the transcription of MMP9 to suppress the invasion and migration of breast cancer cells via HDAC1-mediated p65 deacetylation.

Journal: Cell death & disease

Published: November 22, 2023

Correction: α-Catenin acetylation is essential for its stability and blocks its tumor suppressor effects in breast cancer through Yap1.

Correction: α-Catenin acetylation is essential for its stability and blocks its tumor suppressor effects in breast cancer through Yap1.

Journal: Cancer gene therapy

Published: September 22, 2023

α-Catenin acetylation is essential for its stability and blocks its tumor suppressor effects in breast cancer through Yap1.

α-Catenin acetylation is essential for its stability and blocks its tumor suppressor effects in breast cancer through Yap1.

Journal: Cancer gene therapy

Published: June 09, 2023

CHD4-induced up-regulation of ERα activity contributes to breast cancer progression.

CHD4-induced up-regulation of ERα activity contributes to breast cancer progression.

Journal: Genes & diseases

Published: March 29, 2023

USP13 promotes breast cancer metastasis through FBXL14-induced Twist1 ubiquitination.

USP13 promotes breast cancer metastasis through FBXL14-induced Twist1 ubiquitination.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: January 23, 2023

Cryptochrome 2 acetylation attenuates its antiproliferative effect in breast cancer.

Cryptochrome 2 acetylation attenuates its antiproliferative effect in breast cancer.

Journal: Cell death & disease

Published: December 16, 2022

Author Correction: FBXL10 promotes EMT and metastasis of breast cancer cells via regulating the acetylation and transcriptional activity of SNAI1.

Author Correction: FBXL10 promotes EMT and metastasis of breast cancer cells via regulating the acetylation and transcriptional activity of SNAI1.

Journal: Cell death discovery

Published: December 05, 2022

Showing 1-12 of 56

Last Updated: 09/26/2026